NB

Navneet Bhardwaj

Active Director Director DIN 00117325
DIN 00117325 First appointment May 2024 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2024
Shareholding value •••• Premium profile

About Navneet Bhardwaj

Data last updated:

Navneet Bhardwaj is a Director at Maxlife Drugs Private Limited (since 2024). The company operates in Pharma. Maxlife Drugs Private Limited reported revenue of ₹47,820 (FY 2025).

DIN 00117325
Primary Designation Director
Industry Pharma
First Appointment 27 May 2024
Oldest Company Age 20 yrs
Largest company Maxlife Drugs Private Limited · ₹47,820 (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Maxlife Drugs Private Limited U85121DL2006PTC149174
Director27 May 20242006₹47,820 (FY 2025)Active

Board colleagues of Navneet Bhardwaj

Directorship timeline

Open interactive timeline →
Maxlife Drugs Private Limited
Premium access

Shareholding and investment profile for Navneet Bhardwaj

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Navneet Bhardwaj

Navneet Bhardwaj currently holds 1 directorship: Maxlife Drugs Private Limited (Director, since 27 May 2024, revenue ₹47,820 (FY 2025)).

Navneet Bhardwaj was first appointed on 27 May 2024 as Director at Maxlife Drugs Private Limited.

The current boards of Navneet Bhardwaj's companies include Ankit Sharma (Maxlife Drugs Private Limited), Ankur Sharma (Maxlife Drugs Private Limited), Ganga Saran Sharma (Maxlife Drugs Private Limited), Shashi Sharma (Maxlife Drugs Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available